Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
Innovotech ( (TSE:IOT) ) has shared an update.
Innovotech Inc. has expanded its agreement with Bernard Grobbelaar as fractional CFO, granting him 150,000 stock options, and has relocated its head office and laboratory to a new space in Edmonton. This move is aimed at consolidating operations to enhance efficiency and reduce costs, with a flexible lease allowing for future growth opportunities.
More about Innovotech
Innovotech Inc. is a Canadian technology company involved in specialized laboratory services, biotechnology, and proprietary intellectual property. It operates several subsidiaries, including Innovotech Labs Corporation, which provides antimicrobial testing devices and solutions, and Keystone Labs Inc., serving the Canadian pharmaceutical and industrial markets. Innovotech also holds a majority stake in NouLifeSciences Inc., which focuses on antioxidant molecules for cosmetics and medical applications.
Average Trading Volume: 32,953
Technical Sentiment Signal: Buy
Current Market Cap: C$10.55M
For an in-depth examination of IOT stock, go to TipRanks’ Overview page.